British School Kids With Diabetes Gain First Time Freedom From Injections With New Insulin Pump Guidelines Sep 1, 2008
(iii) Barnard, K.D., study as above (iv) Diabetes UK, Insulin Pump Services - Report of the Insulin Pumps Working Group, March 2007 (v) University of Bristol, March 2007 (PJ Bingley, Department of Clinical Science) (vi) University of Bristol, March 2007 (PJ Bingley, Department of Clinical Science) (vii) Encyclopedia of Endocrine Diseases, Volume 3, p48. Insulin Secretion Physiology. (PR Newswire)
Like Owner, Like Dog: One Third Of US Dogs Are Obese, Cats Also Suffer Feb 22, 2008
There are also endocrine diseases that are associated with obesity that must also be considered and ruled out, before the pet undergoes weight reduction, said Thatcher. Like humans, there are also many health problems associated with being obese. (Science Daily)
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma Dec 4, 2007
The Company creates innovative medicines and products for women s and reproductive health, endocrine diseases and cell-based therapies. With a proven track record of developing and commercializing products in its key therapeutic areas, the Company also has an internal pipeline of new products in development in women s and reproductive health and hormonal cancer therapy. (BusinessWire)
Kids mature faster due to diet, porn Sep 5, 2007
The number of children experiencing the early onset of puberty has doubled over the past 10 years, according to a survey analyzing children's endocrine diseases by the Women and Children's Hospital of Guangdong Province. The survey found the average age for the onset of puberty of Guangzhou's children dropped to 11 years old from the previous age of 13. (Xinhuanet, China)
Pfizer Inc UK Regulatory Announcement: Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009 Aug 7, 2007
The pipeline includes 20 potential treatments for cancer; 16 for cardiovascular, metabolic and endocrine diseases; 17 for pain and inflammation; 17 for neurological disorders and 10 for infectious diseases ... Pfizer continues to build on its traditional strengths in cardiovascular research and has expanded in metabolic and endocrine diseases. (BusinessWire)
Two govt hospitals to adopt 'Full Paying Patient' concept Jul 27, 2007
Dr Chua said the ministry picked the two hospitals as they were excellent medical centres in treating liver related illness, hand surgery, breast cancer, endocrine diseases and some other illness. He said many who could afford sought treatment at these hospitals, but without the full paying patient concept, they only paid the minimal rate and enjoyed the subsidised treatment. (The Star Online, Malaysia -- News)
Rise in abortions marks a changing society in China May 13, 2007
However, Xu noted that young women who have multiple abortions are more susceptible to problems like infertility, hemorrhaging, endocrine diseases and endometriosis. A recent survey of 8,846 single and married women at 10 hospitals in Beijing found that 36 percent had had more than one abortion within six months. (International Herald Tribune)
High risk of chronic health conditions plagues those with schizophrenia Dec 13, 2006
In the new study, Dr. Carney Doebbeling and colleagues report that compared with individuals without mental illness, persons with schizophrenia were more likely to have a greater number of conditions spanning several disease categories including cardiovascular, pulmonary, neurological, and endocrine diseases. One-third of a rather young population (average age of those with schizophrenia was 40 years old) already had three or more chronic physical health conditions needing a physicians care. (EurekAlert!)
Pfizer raises earnings guidance Dec 1, 2006
Areas of concentration include cardiovascular, metabolic and endocrine diseases focusing on atherosclerosis, obesity, diabetes, bone and muscle health, and blood clots. Search. (Globe and Mail -- Business)
Manhattan Pharmaceuticals' Alan G. Harris, MD, PhD to Chair Metabolic Syndrome Conference Sep 19, 2006
Other expert speakers to be featured at the conference include: Douglas Greene, MD, Chief Medical Officer, sanofi-aventis; Rebecca Taub, MD, VP Research-Metabolic Diseases, Hoffman La-Roche; Tu Nguyen, MD, Director-Cardiovascular, Metabolic & Endocrine Diseases, Pfizer Global Research & Development; Pierre Rosensweig, MD, VP-Internal Medicine Clinical Development, sanofi-aventis; Karsten Wassermann, PhD, DSc, Project VP-Clinical Development, Medical & Regulatory Affairs, Novo Nordisk; and David... (Primezone Releases)
Neurocrine Announces Employee Stock Option Exchange Program Aug 26, 2006
"Neurocrine has recently experienced a number of setbacks and a recent restructuring. Our employees are the Company's most important asset and we strongly believe that our shareholders will benefit by ensuring that our employees are motivated and committed to the success of the Company. As we rebuild the Company and move forward to advance indiplon through regulatory approval, advance our other high priority programs and continue to build our research and development pipeline, our Board of... (PR Newswire)
Neurocrine Announces San Diego Campus Restructuring Aug 8, 2006
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, irritable bowel syndrome, and CNS related disorders. (PR Newswire)
Biotech fires entire sales force Jul 27, 2006
Based in Carmel Valley, Neurocrine Biosciences is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. It doesn't have any products to date, but it is trying to develop products to help customers with anxiety, depression, insomnia, diabetes and irritable bowel syndrome. (North County Times)
Neurocrine and Pfizer Terminate Collaboration Agreement for Indiplon Jun 23, 2006
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, irritable bowel syndrome, eating disorders, pain, and autoimmunity. (PR Newswire)
Neurocrine Completes Review of Indiplon Action Letters Jun 16, 2006
"We will make final plans for the NDA resubmissions once we have clarified this in conference with the FDA. We are also expecting to amend financial guidance in our second quarter financial webcast." Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, irritable bowel syndrome,... (PR Newswire)
Bob Harper of NBC's 'The Biggest Loser' Partners With National Diabetes Experts to Help Americans 'Step Up' Their Diabetes Management Jun 8, 2006
Members contribute on a regular and continuing basis to the scientific literature on endocrine diseases and conduct medical education programs on this subject. For more information on AACE, please visit or. (Yahoo! Wire -- Entertainment News)
Put a leash on pet obesity Jan 20, 2006
Overweight pets are also more prone to hip dysplasia, back and joint pain, and endocrine diseases. To make matters worse, the extra weight can make it more difficult for a veterinarian to manage these conditions both medically and surgically. (Concord Journal, MA)
